2023
DOI: 10.1097/mph.0000000000002632
|View full text |Cite
|
Sign up to set email alerts
|

Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia: [RETRACTED]

Abstract: Objective: Polo-like kinase 1 (PLK1) modulates leukemia cell apoptosis, proliferation, and cell cycle arrest in the progression of acute lymphoblastic leukemia (ALL). This study intended to investigate the dysregulation of PLK1 and its association with induction therapy response and prognosis in pediatric ALL patients. Materials and Methods: Bone marrow mononuclear cell samples were collected from 90 pediatric ALL patients at baseline and on the 15th da… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…At the request of the authors, the Editors and Publisher retract the article “Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia” by Zhao et al 1 published ahead of print on February 20, 2023. Due to authors return to trace the data of the article recently, they observed that some data needs further check to confirm, and according to their latest regulations, Journal of Pediatric Hematology/Oncology was not included in the designated submission journals.…”
mentioning
confidence: 99%
“…At the request of the authors, the Editors and Publisher retract the article “Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good Treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia” by Zhao et al 1 published ahead of print on February 20, 2023. Due to authors return to trace the data of the article recently, they observed that some data needs further check to confirm, and according to their latest regulations, Journal of Pediatric Hematology/Oncology was not included in the designated submission journals.…”
mentioning
confidence: 99%